Homebiotech

biotech

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Servier acquiring Edgewise Therapeutics’ muscular dystrophy business

Jim Cornall - June 9, 2026

biotech

Antibody fragment prevents haemorrhages associated with new Alzheimer’s treatments

Jim Cornall - June 8, 2026

biotech

Fast Track Designation for Lynch syndrome-associated cancers treatment

Jim Cornall - June 8, 2026

biotech

Positive data from linear IgA disease study

Jim Cornall - June 8, 2026

biotech

Base to Base biotech podcast 62: A new approach to strokes

Jim Cornall - June 5, 2026

biotech

Blood and biomarker testing service launches in Scotland for earlier Alzheimer’s diagnosis

Jim Cornall - June 4, 2026

biotech

Partnership looks to accelerate next‑generation brain treatments

Jim Cornall - June 4, 2026

biotech

Positive results for C. difficile vaccine

Jim Cornall - June 4, 2026

1...141516...96 Page 15 of 96

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026 0

On a genetic level, RNA viruses share common structural elements. The RNA of their genomes has strings, folds, and knot-like features that interact with...

Base to Base biotech podcast 72: Cell-free DNA bioproduction

biotech Jim Cornall - August 21, 2026 0

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0